Back to Screener

Healthcare

Fresenius Medical Care AG & Co. KGaA(FMCQF)

Live Price

Offline

$45.17

+0.00% today

1Y Change

-22.25%

Window

Jun 30, 2025 โ†’ Jun 23, 2026

Market Cap
$10.01B
Revenue Growth
+1.5%
EPS Growth
+83.1%
Dividend Yield
4.0%

Coverage: 246 bars ยท Jun 30, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Fresenius Medical Care AG & Co. KGaA (FMCQF) is a Healthcare stock with a market cap of $10.01B and listed on OTC. The stock last traded around $45.17 and down 22.3% across the available one-year price window (Jun 30, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +1.5%, EPS growth of +83.1%, a dividend yield of 4.0%. What stands out right now is revenue +1.5%, EPS +83.1%, free cash flow +4.6% with operating margin 9.6% and ROIC 6.0%. The dividend matters to the case here, with a current yield around 4.0%. Valuation is more restrained than many high-expectation growth names at P/E 10.4 and price/sales 0.5. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines FMCQF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

FMCQF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

FMCQF trails SPY

FMCQF is 40.99 pts behind over the shared 1Y window.

FMCQF had 18.58 pts deeper max drawdown than SPY.

FMCQF beat SPY in 0 of 2 calendar years shown and trailed in 2.

FMCQF

-22.25%

Normalized return

SPY

+18.73%

S&P 500

Excess Return

-40.99 pts

Relative to SPY

FMCQF Max Drawdown

-27.71%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

FMCQFSPY

Calendar-Year Returns

Uses the longest available daily history for FMCQF and SPY.

YearFMCQFSPYExcessLeader
2026-2.90%+6.71%-9.61 ptsSPY
2025-19.93%+11.19%-31.12 ptsSPY

Unable to load analyst forecasts.

Timed out loading forecasts for FMCQF

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.